Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells

Immunology

Volumn 99, Issue 1, 2000, Pages 1-7

  Tascon, R E ^a   Ragno, S ^a   Lowrie, D B ^a   Colston, M J ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GAMMA INTERFERON;

ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CYTOKINE PRODUCTION; CYTOTOXICITY; DENDRITIC CELL; FEMALE; IMMUNOSTIMULATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CPG ISLANDS; DENDRITIC CELLS; DNA, BACTERIAL; FEMALE; FLOW CYTOMETRY; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTORS, ANTIGEN, T-CELL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, CYTOTOXIC; VACCINES, SYNTHETIC;

EID: 0033980658     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2000.00941.x     Document Type: Article

References (24)

1. 1. Pardoll D.M. & Beckerleg A.M. (1995) Exposing the immunology of naked DNA vaccines. Immunity 3, 165.
2. 2. Fynan E.F., Webster R.G., Fuller D.H. et al. (1993) DNA vaccines: protective immunization by parental, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90, 11478.
3. 3. Ulmer J.B., Donnelly J.J., Parker S.E. et al. (1993) Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745.
4. 4. Tascon R.E., Colston M.J., Ragno S., Stavropoulos E., Gregory D. & Lowrie D.B. (1996) Vaccination against tuberculosis by DNA injection. Nat Med 2, 888.
5. 5. Cheider J., Gilbert S.C., Blanchard T.J. et al. (1998) Enhanced immunogenicity for CD8 T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus ankara. Nat Med 4, 397.
6. 6. Carson D.A. & Raz E. (1997) Oligonucleotide adjuvants for T helper 1 (th-1)-specific vaccination. J Exp Med 10, 1621.
7. 7. Roman M.E., Martin-Orozco S., Goodman M.D. et al. (1997) Immunostimulatory DNA sequences function as T helper-1 promoting adjuvants. Nat Med 3, 849.
8. 8. Krieg A.M., Yi A.K., Matson S. et al. (1995) CpG motifs in bacterial DNA trigger direct B cell activation. Nature 374, 546.
9. 9. Sato Y., Roman H., Tighe D. et al. (1996) Immunostimulatory DNA sequences arc necessary for effective intradermal DNA gene immunization. Science 273, 352.
10. 10. Chu R.S., Targoni O.S., Krieg A.M., Lehman P.V. & Harding C.V. (1997) CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J Exp Med 186, 1623.
11. 11. Condon C., Watkins S.C., Celluzi C.M., Thomson K. & Falo L.D. (1996) DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2, 1122.
12. 12. Mamalaki C., Norton T., Tanaka Y. et al. (1992) Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc Natl Acad Sci USA 89, 11342.
13. 13. Volkmann A., Neefies J. & Stockingler B. (1996) A conditionally immortalized dendritic cell line which differentiates in contact with T cells or T cell derived cytokines. Eur J Immunol 26, 2565.
14. 14. Matzinger P. (1991) The JAM test. J Immunol Methods 145, 185.
15. 15. Walker B.K., Butler R. & Colston M.J. (1989) The role of th1 lymphocytes in the development of protective immunity against Mycobacterium leprae. Analysis of lymphocyte function by polymerase chain reaction detection of cytokine messenger RNA. J Immunol 148, 1885.
16. 16. Croft M., Carter L., Swain S.L. & Dutton R.W. (1994) Generation of polarized antigen specific CD8 effector populations: reciprocal action of IL-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med 180, 1715.
17. 17. Bonato V.L., Lima V.M., Tascon R.E., Lowrie D.B. & Silva C.L. (1998) Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice. Infect Immun 66, 169.
18. 18. Casares S., Inaba K., Brumeanu T.D., Steinman R.M. & Bona C.A. (1997) Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope. J Exp Med 186, 1481.
19. 19. Akbari O., Panjwani N., Garcia S., Tascon R., Lowrie D. & Stockinger B. (1999) DNA vaccination: transfection and activation of dendritic cells as key events for immunity. J Exp Med 189, 169.
20. 20. Sparwasser T., Koch E.S., Vabulas R.M. et al. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur J Immunol 28, 2045.
21. 21. Yi A.-K., Tuetken R., Redford T., Waldschmidt M., Kirsch J., Krieg A. (1998) CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 160, 4755.
22. 22. Ulmer J.B., Deck R.R., Dewitt C.M., Donnelly J.I. & Lie M.A. (1996) Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunology 89, 59.
23. 23. Corr M., Lee D.J., Carson D.A. & Tighe H. (1996) Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J Exp Med 184, 1555.
24. 24. Sun S.; Kishimoto H. & Sprent J. (1998) DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med 187, 1145.